BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 8496677)

  • 21. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
    J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
    Greten TF; Slansky JE; Kubota R; Soldan SS; Jaffee EM; Leist TP; Pardoll DM; Jacobson S; Schneck JP
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7568-73. PubMed ID: 9636190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.
    Kubota R; Soldan SS; Martin R; Jacobson S
    J Neurovirol; 2002 Feb; 8(1):53-7. PubMed ID: 11847592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
    Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR
    Virology; 1996 Mar; 217(1):139-46. PubMed ID: 8599198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
    Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
    J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
    Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
    Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.
    Höllsberg P; Weber WE; Dangond F; Batra V; Sette A; Hafler DA
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4036-40. PubMed ID: 7732026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.
    Ozden S; Cochet M; Mikol J; Teixeira A; Gessain A; Pique C
    J Virol; 2004 Oct; 78(19):10320-7. PubMed ID: 15367598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy.
    Taylor GP; Hall SE; Navarrete S; Michie CA; Davis R; Witkover AD; Rossor M; Nowak MA; Rudge P; Matutes E; Bangham CR; Weber JN
    J Virol; 1999 Dec; 73(12):10289-95. PubMed ID: 10559346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
    Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Suzuki J; Kira J; Baba E; Nakamura M; Koyanagi Y; Nakamura T; Kawano Y; Yamasaki K; Shirabe S; Hatano N; Hayashi K; Yamamoto N; Kobayashi T
    J Infect Dis; 1996 May; 173(5):1115-22. PubMed ID: 8627062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
    Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
    Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
    J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
    Kitze B; Usuku K; Izumo S; Nakamura M; Shiraki H; Ijichi S; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
    J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
    J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.